Alan Rembach

Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment

Lesley Cheng, James D. Doecke, Robyn A. Sharples et al. · Molecular Psychiatry · 2014 · 401 citations · Full text

Neuroimaging Biomarkers, Neurodegenerative Diseases, Neuropsychology +9

PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses

Noel G. Faux, Craig Ritchie, Adam P. Gunn et al. · Journal of Alzheimer s Disease · 2010 · 388 citations · Full text

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +15

Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1

Julie D. Atkin, Manal A. Farg, Bradley J. Turner et al. · Journal of Biological Chemistry · 2006 · 276 citations · Full text

Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis

Bradley J. Turner, Julie D. Atkin, Manal A. Farg et al. · Journal of Neuroscience · 2005 · 191 citations · Full text

Neurodegenerative Diseases, Mutant Sod1 Secretion, Amyotrophic Lateral Sclerosis +13

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Christopher Fowler, Stephanie R. Rainey‐Smith, Sabine Bird et al. · Journal of Alzheimer s Disease Reports · 2021 · 162 citations · Full text